Eloise Hudry

Eloise Hudry

Company: Novartis AG

Job title: Director & Head of Investigative Translational Toxicology


Non-Clinical Strategies for Toxicological Evaluation of siRNA for CNS Disorders 11:30 am

Exploring considerations beyond ICH landscape in meeting regulatory expectations of siRNAs Nonclinical evaluation and cross reactivity of siRNAs: tailoring for species selection in siRNA programs Key parameters for toxicology studies: exploring route of administration, dosing regimen and repeat dosing for the future of patient treatmentRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.